Moonlake Immunotherapeutics (MLTX) PT Raised to $30 at Needham
Tweet Send to a Friend
(Updated - May 12, 2026 7:14 AM EDT)
Needham analyst Serge Belanger raised the price target on Moonlake Immunotherapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Needham analyst Serge Belanger raised the price target on Moonlake Immunotherapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
